Company
Spanios Labs
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Spanios Labs harnesses the powerful capabilities of Patient Derived Organoids (PDOs) to accelerate the drug development process for rare cancers. Their platform uses patient-derived 3D tumor models that enable scientists to fast-track the search for novel cures and bring hope to millions of patients.
Loading relationship preview